3,054
Views
11
CrossRef citations to date
0
Altmetric
Articles

Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography

ORCID Icon, , , , , , & show all

References

  • Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187–1193.
  • Rund D, Rachmilewitz E. Β-thalassemia. N Engl J Med. 2005;353:1135–1146.
  • Prati D, Maggioni M, Milani S, et al. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004;89:1179–1186.
  • Cohen AR. Thalassemia. Hematology 2004;2004:14–34.
  • Al-Riyami AA, Suleiman AJ, Afifi M, et al. A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J. 2001;7:1004–1011.
  • Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North America. Blood. 2004;104:34–39.
  • Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol. 2003;38:38–53.
  • EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66:153–194.
  • Sarvazyan AP, Rudenko OV, Swanson SD, et al. Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics. Ultrasound Med Biol. 1998;24:1419–1435.
  • Di Marco V, Bronte F, Cabibi D, et al. Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition. Br J Haematol. 2010;148:476–479.
  • Ferraioli G, Lissandrin R, Tinelli C, et al. Liver stiffness assessed by transient elastography in patients with β thalassaemia major. Ann Hepatol. 2016;15:410–417.
  • Mirault T, Lucidarme D, Turlin B, et al. Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. Eur J Haematol. 2008;80:337–340.
  • Hamidieh AA, Shazad B, Ostovaneh MR, et al. Noninvasive measurement of liver fibrosis using transient elastography in pediatric patients with major thalassemia who are candidates for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:1912–1917.
  • Song P, Macdonald M, Behler R, et al. Two-dimensional shear-wave elastography on conventional ultrasound scanners with time-aligned sequential tracking (TAST) and comb-push ultrasound shear elastography (CUSE). IEEE Trans Ultrason Ferroelectr Freq Control. 2015;62:290–302.
  • Daar S, Hussein HM, Merghoub T, et al. Spectrum of beta-thalassemia mutations in Oman. Ann N Y Acad Sci. 1998;850:404–406.
  • Sporea I, Bota S, Gradinaru-Taşcău O, et al. Which are the cut-off values of 2d-shear wave elastography (2d-swe) liver stiffness measurements predicting different stages of liver fibrosis, considering transient elastography (TE) as the reference method? Eur J Radiol. 2014;83:e118–e122.
  • Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis c. The French metavir cooperative study group. Hepatology. 1994;20:15–20.
  • Team RC. R – a language and environment for statistical computing. Vienna: Rfoundation for statistical computing; 2006. ISBN3-900051-07-0; 2014. Available from: http://www.R-project.org
  • Friedrich-Rust M, Lupsor M, de Knegt R, et al. Point shear wave elastography by acoustic radiation force impulse quantification in comparison to transient elastography for the noninvasive assessment of liver fibrosis in chronic hepatitis c: a prospective international multicenter study. Ultraschall Med. 2015;36:239–247.
  • Ferraioli G, Parekh P, Levitov AB, et al. Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med. 2014;33:197–203.
  • Elalfy MS, Esmat G, Matter RM, et al. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis c virus and compliance with chelation. Ann Hepatol. 2013;12:54–61.
  • Fraquelli M, Cassinerio E, Roghi A, et al. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol. 2010;85:564–568.
  • Maira D, Cassinerio E, Marcon A, et al. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT). Ann Hematol. 2017;96:1931–1936.
  • Sinakos E, Perifanis V, Vlachaki E, et al. Is liver stiffness really unrelated to liver iron concentration? Br J Haematol. 2010;150:247–248.
  • Daar S, Pathare AV. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol. 2006;85:315–319.
  • Rigamonti C, Andorno S, Maduli E, et al. Gender and liver fibrosis in chronic hepatitis: the role of iron status. Aliment Pharmacol Ther. 2005;21:1445–1451.
  • Marsella M, Borgna-Pignatti C, Meloni A, et al. Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a t2* magnetic resonance imaging study. Haematologica. 2011;96:515–520.
  • Proteggente AR, England TG, Rehman A, et al. Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals. Free Radic Res. 2002;36:157–162.
  • Karanjia RN, Crossey MM, Cox IJ, et al. Hepatic steatosis and fibrosis: non-invasive assessment. World J Gastroenterol. 2016;22:9880–9897.
  • Poynard T, Pham T, Perazzo H, et al. Real-time shear wave versus transient elastography for predicting fibrosis: applicability, and impact of inflammation and steatosis. A non-invasive comparison. PLoS One. 2016;11:e0163276.